When Type 1 Diabetes Comes With Other Autoimmune Conditions: Why Getting a Formal Diagnosis Matters

Autoimmune polyendocrine syndrome, or APS, is a pattern in which someone develops multiple autoimmune diseases. The word "polyendocrine" refers to the glands in the body's endocrine system, such as the pancreas (where Type 1 diabetes begins) and the thyroid. However, APS can also include other autoimmune conditions beyond gland-related diseases.

If you have Type 1 diabetes and have also been diagnosed with thyroid disease (autoimmune thyroid disease, or AITD) or celiac disease, you technically meet the criteria for APS. This is an important distinction because it signals that your immune system has a broader tendency toward autoimmunity.

In a recent study, researchers looked at 198 people who met the clinical criteria for APS based on having Type 1 diabetes plus thyroid disease or celiac disease. However, only 17 of those 198 patients—less than 9%—had "autoimmune polyendocrine syndrome" formally written down in their medical records.

This gap between who qualifies for the diagnosis and who actually receives it matters. When a diagnosis isn't formally recognized, it can fade from doctors' awareness over time, even though the underlying risk for additional autoimmune diseases remains present.

The research team conducted extended screening—broader testing for autoantibodies and autoimmune diseases—in people who met APS criteria. What they found was striking: in 39% of patients, screening uncovered new autoantibody positivity (signs of autoimmunity that hadn't been detected before), and in 11.5% of patients, doctors found evidence of new autoimmune diseases altogether.

These findings suggest that many people living with Type 1 diabetes and concurrent autoimmune conditions have additional autoimmunity that goes undetected in routine care.

Current medical guidelines already recommend that doctors screen people with Type 1 diabetes for thyroid disease and celiac disease. When those screenings come back positive, however, many practices don't have a clear next step.

The researchers argue that formal recognition of APS is the key first step. Documenting the diagnosis in a patient's medical record signals an elevated risk for future autoimmune conditions and helps trigger ongoing vigilance throughout a person's life. This isn't about ordering extensive screening panels on everyone, but rather about organizing the clinical picture so that doctors stay alert.

A patient with formally documented APS might receive more regular follow-up monitoring, earlier testing if new symptoms appear, and better continuity of care as they move between doctors over the years.

Source: Endocrine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.